aTYR PHARMA INC Net Income (Loss) Attributable to Noncontrolling Interest
aTYR PHARMA INC (ATYR) reported Net Income (Loss) Attributable to Noncontrolling Interest of -$1.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAttributableToNoncontrollingInterest · last filed 2026-08-07
- aTYR PHARMA INC net income (loss) attributable to noncontrolling interest for the quarter ending 2026-06-30 was -$1.00K.
- aTYR PHARMA INC net income (loss) attributable to noncontrolling interest for the quarter ending 2026-03-31 was -$1.00K.
- aTYR PHARMA INC net income (loss) attributable to noncontrolling interest for the quarter ending 2025-12-31 was -$1.00K.
- aTYR PHARMA INC net income (loss) attributable to noncontrolling interest for the quarter ending 2025-09-30 was -$2.00K.
- aTYR PHARMA INC net income (loss) attributable to noncontrolling interest for fiscal 2025 was -$5.00K, a 600.00% decline from fiscal 2024.
- aTYR PHARMA INC net income (loss) attributable to noncontrolling interest for fiscal 2024 was $1.00K.
- aTYR PHARMA INC net income (loss) attributable to noncontrolling interest for fiscal 2023 was -$8.00K.
- aTYR PHARMA INC net income (loss) attributable to noncontrolling interest for fiscal 2022 was -$5.00K.
| Period end | Net Income (Loss) Attributable to Noncontrolling Interest 3 month | Net Income (Loss) Attributable to Noncontrolling Interest 6 month | Net Income (Loss) Attributable to Noncontrolling Interest 9 month | Net Income (Loss) Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$1.00K 10-Q · filed 2026-08-07 | -$2.00K 10-Q · filed 2026-08-07 | -$3.00K derived: sum of 3 quarters · filed 2026-08-07 | -$5.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | -$1.00K 10-Q · filed 2026-05-15 | -$2.00K derived: sum of 2 quarters · filed 2026-05-15 | -$4.00K derived: sum of 3 quarters · filed 2026-05-15 | -$5.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | -$3.00K derived: sum of 2 quarters · filed 2026-03-05 | -$4.00K derived: sum of 3 quarters · filed 2026-08-07 | -$5.00K 10-K · filed 2026-03-05 |
| 2025-09-30 | -$2.00K 10-Q · filed 2025-11-06 | -$3.00K derived: sum of 2 quarters · filed 2026-08-07 | -$4.00K 10-Q · filed 2025-11-06 | -$5.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | -$1.00K 10-Q · filed 2026-08-07 | -$2.00K 10-Q · filed 2026-08-07 | -$3.00K derived: sum of 3 quarters · filed 2026-08-07 | -$5.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | -$1.00K 10-Q · filed 2026-05-15 | -$2.00K derived: sum of 2 quarters · filed 2026-05-15 | -$4.00K derived: sum of 3 quarters · filed 2026-05-15 | -$4.00K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | -$3.00K derived: sum of 2 quarters · filed 2026-03-05 | -$3.00K derived: sum of 3 quarters · filed 2026-03-05 | $1.00K 10-K · filed 2026-03-05 |
| 2024-09-30 | -$2.00K 10-Q · filed 2025-11-06 | -$2.00K derived: sum of 2 quarters · filed 2025-11-06 | $2.00K 10-Q · filed 2025-11-06 | $1.00K derived: sum of 4 quarters · filed 2026-03-05 |
| 2024-06-30 | $0.00 10-Q · filed 2025-08-07 | $4.00K 10-Q · filed 2025-08-07 | $3.00K derived: sum of 3 quarters · filed 2026-03-05 | $1.00K derived: sum of 4 quarters · filed 2026-03-05 |
| 2024-03-31 | $4.00K 10-Q · filed 2025-05-07 | $3.00K derived: sum of 2 quarters · filed 2026-03-05 | $1.00K derived: sum of 3 quarters · filed 2026-03-05 | -$3.00K derived: sum of 4 quarters · filed 2026-03-05 |
| 2023-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | -$3.00K derived: sum of 2 quarters · filed 2026-03-05 | -$7.00K derived: sum of 3 quarters · filed 2026-03-05 | -$8.00K 10-K · filed 2026-03-05 |
| 2023-09-30 | -$2.00K 10-Q · filed 2024-11-07 | -$6.00K derived: sum of 2 quarters · filed 2024-11-07 | -$7.00K 10-Q · filed 2024-11-07 | -$9.00K derived: sum of 4 quarters · filed 2025-03-13 |
| 2023-06-30 | -$4.00K 10-Q · filed 2024-08-13 | -$5.00K 10-Q · filed 2024-08-13 | -$7.00K derived: sum of 3 quarters · filed 2025-03-13 | -$8.00K derived: sum of 4 quarters · filed 2025-03-13 |
| 2023-03-31 | -$1.00K 10-Q · filed 2024-05-02 | -$3.00K derived: sum of 2 quarters · filed 2025-03-13 | -$4.00K derived: sum of 3 quarters · filed 2025-03-13 | -$5.00K derived: sum of 4 quarters · filed 2025-03-13 |
| 2022-12-31 | -$2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | -$3.00K derived: sum of 2 quarters · filed 2025-03-13 | -$4.00K derived: sum of 3 quarters · filed 2025-03-13 | -$5.00K 10-K · filed 2025-03-13 |
| 2022-09-30 | -$1.00K 10-Q · filed 2023-11-09 | -$2.00K derived: sum of 2 quarters · filed 2023-11-09 | -$3.00K 10-Q · filed 2023-11-09 | -$5.00K derived: sum of 4 quarters · filed 2024-03-14 |
| 2022-06-30 | -$1.00K 10-Q · filed 2023-08-09 | -$2.00K 10-Q · filed 2023-08-09 | -$4.00K derived: sum of 3 quarters · filed 2024-03-14 | -$6.00K derived: sum of 4 quarters · filed 2024-03-14 |
| 2022-03-31 | -$1.00K 10-Q · filed 2023-05-09 | -$3.00K derived: sum of 2 quarters · filed 2024-03-14 | -$5.00K derived: sum of 3 quarters · filed 2024-03-14 | -$6.00K derived: sum of 4 quarters · filed 2024-03-14 |
| 2021-12-31 | -$2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | -$4.00K derived: sum of 2 quarters · filed 2024-03-14 | -$5.00K derived: sum of 3 quarters · filed 2024-03-14 | -$9.00K 10-K · filed 2024-03-14 |
| 2021-09-30 | -$2.00K 10-Q · filed 2022-11-14 | -$3.00K derived: sum of 2 quarters · filed 2022-11-14 | -$7.00K 10-Q · filed 2022-11-14 | -$10.00K derived: sum of 4 quarters · filed 2023-03-14 |
| 2021-06-30 | -$1.00K 10-Q · filed 2022-08-15 | -$5.00K 10-Q · filed 2022-08-15 | -$8.00K derived: sum of 3 quarters · filed 2023-03-14 | -$9.00K derived: sum of 4 quarters · filed 2023-03-14 |
| 2021-03-31 | -$4.00K 10-Q · filed 2022-05-10 | -$7.00K derived: sum of 2 quarters · filed 2023-03-14 | -$8.00K derived: sum of 3 quarters · filed 2023-03-14 | -$9.00K derived: sum of 4 quarters · filed 2023-03-14 |
| 2020-12-31 | -$3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | -$4.00K derived: sum of 2 quarters · filed 2023-03-14 | -$5.00K derived: sum of 3 quarters · filed 2023-03-14 | -$6.00K 10-K · filed 2023-03-14 |
| 2020-09-30 | -$1.00K 10-Q · filed 2021-11-12 | -$2.00K derived: sum of 2 quarters · filed 2021-11-12 | -$3.00K 10-Q · filed 2021-11-12 | |
| 2020-06-30 | -$1.00K 10-Q · filed 2021-08-11 | -$2.00K 10-Q · filed 2021-08-11 | ||
| 2020-03-31 | -$1.00K 10-Q · filed 2021-05-14 | |||
| 2019-12-31 | -$160.00K 10-K · filed 2022-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B |